Metraipolis › archive › dc_48bddea7f874
Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin — Europe PMC PMID:41614077
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41614077
- DOI
- 10.3389/fphar.2025.1727729
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T19:46:41.051Z
- SHA-256 of the archived text
9db47529fb468615e31258cacb96079d0a4638cd647ea88db90bd6a0cea1f626- Stable URL of this page
https://metraipolis.com/documento/dc_48bddea7f874
How to cite
Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin — Europe PMC PMID:41614077 — Europe PMC (en), https://europepmc.org/article/MED/41614077 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_48bddea7f874 (Metraipolis archive dc_48bddea7f874, sha256 9db47529fb468615e31258cacb96079d0a4638cd647ea88db90bd6a0cea1f626)
BibTeX
@misc{dc48bddea7f874,
title = {Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin — Europe PMC PMID:41614077},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41614077},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_48bddea7f874; sha256 9db47529fb468615e31258cacb96079d0a4638cd647ea88db90bd6a0cea1f626},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41614077. Agents can read the archived copy with the MCP tool read_document.